Do you have a report that can help me understand the market of in vitro diagnostics in the US?

Good day,

Thank you for getting in touch with ReportLinker.  Out of our many reports about the in vitro diagnostics industry, we have selected two to help answer your question.

The first one, United States In Vitro Diagnostics (IVD) Market Outlook to 2021 – Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture was published in August 2015 by Global Data.  This 680 page report provides market data on the market size and share, divided into subcategories.  These segments are immuno chemistry, clinical chemistry, infectious diagnostics, hematology, microbiology culture, histology and cystology as well as genetic testing.  The report gives profiles of the key players, information on upcoming products, news and deals.  It also features interviews with industry experts, covering market size, company share and distribution share data.  It looks at historical data from 2007-2014 and makes forecasts to 2021.  The key players covered in the report are F. Hoffmann-La Roche Ltd, Siemens Healthcare, Abbott Laboratories, bioMérieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc and others.

The second report is called Impact of US Healthcare Reform on the In Vitro Diagnostics Market.  It is an 87 page study published by Frost and Sullivan in June 2014.  It highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics market.  It also looks at global trends and the outlook for the IVD market.  The market is segmented into immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis and self-monitoring blood glucose.  The key market drivers, restraints and competitive landscape are also investigated in the report.  The negative effects of the reform include reductions in reimbursements and cost containment measures implemented due to decreased operating margins.  Positive effects include increased prevention and wellness services that will increase test volumes for labs.

We hope this information has been helpful to you.  There is a lot of useful information about the in healthcare industry in ReportLinker’s portal.  If you have any questions or any further needs, please feel free to contact us.